419571-68-9

Basic information

• Product Name: tert-butyl 4-(3-oxobutanoyl)piperidine-1-carboxylate
• Synonyms: tert-butyl 4-(3-oxobutanoyl)piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 4-(1,3-dioxobutyl)-, 1,1-dimethylethyl ester;tert-butyl 4-(1,3-dioxobutyl)piperidine-1-carboxylate;4-(3-Oxo-butyryl)-piperidine-1-carboxylic acid tert-butyl ester
• CAS NO: 419571-68-9
• Molecular Formula: C₁₄H₂₃NO₄
• Molecular Weight: 269.34
• Mol File: 419571-68-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl 4-(3-oxobutanoyl)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(3-oxobutanoyl)piperidine-1-carboxylate(419571-68-9)
• EPA Substance Registry System: tert-butyl 4-(3-oxobutanoyl)piperidine-1-carboxylate(419571-68-9)

Safety Data

• Hazardous Substances Data: 419571-68-9(Hazardous Substances Data)

Usage

Description

Tert-butyl 4-(3-oxobutanoyl)piperidine-1-carboxylate is a chemical compound that serves as an essential reagent in the synthesis of various organic molecules, particularly in the formation of (alkylpyrazolyl)piperidines. It is characterized by its unique structure, which allows for specific chemical reactions and applications in the field of organic chemistry.

Uses

Used in Organic Synthesis:
Tert-butyl 4-(3-oxobutanoyl)piperidine-1-carboxylate is used as a reagent for the regioselective synthesis of (alkylpyrazolyl)piperidines. Its unique structure enables the formation of these complex organic molecules, which can be further utilized in various applications, such as pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, tert-butyl 4-(3-oxobutanoyl)piperidine-1-carboxylate is used as a key intermediate in the synthesis of various drug candidates. Its ability to participate in regioselective reactions allows for the creation of novel compounds with potential therapeutic properties.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, tert-butyl 4-(3-oxobutanoyl)piperidine-1-carboxylate is employed as a reagent for the synthesis of new compounds with potential applications as pesticides, herbicides, or other agricultural chemicals. Its role in the synthesis of these compounds contributes to the development of more effective and environmentally friendly products.

Upstream product

• 84358-13-4 N-[(tert-butoxy)carbonyl]piperidine-4-carboxylic acid 
• 67-64-1 acetone 
• 914654-75-4 1-(1,1-dimethylethyl) 4-piperidinedicarboxylate anhydride with 1H-imidazole-1-carboxylic acid 
• 498-94-2 isonipecotic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 293744-38-4 tert-butyl 4-(1H-imindazole-1-carbonyl)piperidine-1-carboxylate 

Downstream Products

• 1352246-52-6 1-(1-{[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl]carbonyl}piperidin-4-yl)butane-1,3-dione 
• 1352245-02-3 [(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl]{4-[1-(3-chloro-4-fluorophenyl)-3-methyl-1H-pyrazol-5-yl]piperidin-1-yl}methanone 
• 1352246-53-7 tert-butyl (3S,4R)-3-({4-[1-(3-chloro-4-fluorophenyl)-3-methyl-1H-pyrazol-5-yl]piperidin-1-yl}carbonyl)-4-(2,4-difluorophenyl)pyrrolidine-1-carboxylate 
• 1352245-04-5 [4-[2-(3-chloro-4-fluoro-phenyl)-5-methyl-pyrazol-3-yl]-1-piperidyl]-[(3S,4R)-4-(2,4-difluorophenyl)pyrrolidin-3-yl]methanone trifluoroacetate 
• 1470189-73-1 (4-(3-methyl-1-(4-(methylsulphonyl)phenyl)-1H-pyrazol-5-yl)piperidin-1-yl)(p-tolyl)methanone 
• 1470189-75-3 (4-(3-methyl-1-(4-(methylsulphonyl)phenyl)-1H-pyrazol-5-yl)piperidin-1-yl)(4-methoxyphenyl)methanone 
• 1470189-77-5 (4-(3-methyl-1-(4-(methylsulphonyl)phenyl)-1H-pyrazol-5-yl)piperidin-1-yl)(4-nitrophenyl)methanone 
• 1470189-79-7 1-(4-(3-methyl-1-(4-(methylsulphonyl)phenyl)-1H-pyrazol-5-yl)piperidin-1-yl)propan-1-one 
• 1470189-81-1 4-(5-(1-benzoylpiperidin-4-yl)-3-methyl-1H-pyrazol-1-yl)benzenesulphonamide 
• 1470189-83-3 4-(5-(1-(4-chlorobenzoyl)piperidin-4-yl)-3-methyl-1H-pyrazol-1-yl)benzenesulphonamide 
• 1470189-85-5 4-(3-methyl-5-(1-(4-methylbenzoyl)piperidin-4-yl)-1H-pyrazol-1-yl)benzenesulphonamide 
• 1470189-87-7 4-(5-(1-(4-methoxybenzoyl)piperidin-4-yl)-3-methyl-1H-pyrazol-1-yl)benzenesulphonamide 
• 1470189-89-9 4-(3-methyl-5-(1-(4-nitrobenzoyl)piperidin-4-yl)-1H-pyrazol-1-yl)benzenesulphonamide 
• 1470189-91-3 4-(3-methyl-5-(1-propionylpiperidin-4-yl)-1H-pyrazol-1-yl)benzenesulphonamide 

Relevant articles and documents

Design, synthesis and biological evaluation of 4-(1- (4(sulphanilamide) phenyl)-3-(methyl)-1H-pyrazol-5-yl)dine urea and N-acyl derivatives as a soluble epoxide hydrolase inhibitors

A series of novel sEH inhibitors containing a N-substituted piperidine ring [N-urea (8a-i ) (9a-l) and amide derivatives (6a-l) (7a-l )] with pyrazole (a five-membered polar heterocycle) as a pharmacophore lead for sEH inhibition have been designed, synth

SUBSTITUTED CYCLOHEXYL DERIVATIVES AS NK-3 RECEPTOR ANTAGONISTS

The present invention relates to the compounds of formula (I): wherein A,B, n, X, Y, Z, R1, R2, R3, R4, R5, R6, R7 and R8 are defined herein, and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising them and their use in treating diseases mediated by neurokinin-3 (NK-3) receptors. These compounds can thus be used in methods of treatment to suppress and treat such disorders.

N-(3-(4-substituted-1-piperidinyl)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists

The present invention provides a method of treatment of a subject suffering from a disease, such as schizophrenia, for which the administration of an NK-3 antagonist is indicated which comprises administering to that subject a therapeutically effective amount of a compound of formula I: wherein, generally, Q is R1 is benzyl, phenyl, thiophene or imidazolyl optionally substituted with C1-4alkyl or halogen, such as methyl, fluorine or bromine; R2 is hydrogen or C1-4alkyl such as methyl; R3 is phenyl; R4 is hydrogen; R5 is hydrogen or C1-6alkylcarbonyl such as methylcarbonyl; X is —SO2— or —C(O)N(R2)SO2— where R2 is preferably hydrogen; Y is a bond, CH2 or Z1 where Z1 is —N(Rf)— in which Rf is C1-6alkylcarbonyl such as ethylcarbonyl; and R6 is phenyl, pyrazolyl, pyridyl, pyrimidinyl or benzimidazolonyl optionally substituted with one or two groups chosen from C1-6alkyl and benzyl, such as methyl, ethyl and benzyl; or a pharmaceutically acceptable salt thereof.